Showing 2981-2990 of 9401 results for "".
All Dressed Up: Optimal Wound Control to Reduce Scars
https://practicaldermatology.com/topics/skin-cancer-photoprotection/all-dressed-up-optimal-wound-control-to-reduce-scars/20022/Performing more than 25 million surgical procedures each year, dermatologists have the potential to create innumerable scars. Mara Weinstein Velez, MD talks about the best dressings to use to reduce the risk of scars and offers a look at laser-assisted drug delivery to address existing scars.Five easy ways to increase your clickthrough rate
https://practicaldermatology.com/topics/practice-management/five-easy-ways-to-increase-your-clickthrough-rate/19956/Your dermatology website’s placement on the Google search results page is important – but it is not everything. Check out this short video from Ekwa Marketing to discover a few simple ways to improve traffic, no matter where your link is on the search page.Is There Evidence that Topical Formulations Can Support the Microbiome?
https://practicaldermatology.com/topics/atopic-dermatitis/is-there-evidence-that-topical-formulations-can-support-the-microbiome/19826/There is a growing body of research on the importance of the microbiome as well as the potential to support a healthy microbiome through topical product selection, Dr. Friedman says.DermWireTV: AAD Virtual Data Highlights, Cynosure Consumer Data
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-aad-virtual-data-highlights-cynosure-consumer-data/19818/The American Academy of Dermatology 2020 VMX Virtual Conference shines a light on fresh data from UCB, Leo Pharma, Lilly and Dermira, and Soliton. Cassiopea reports long-term data for Clascoterone. Zilxi from Menlo and Foamix approved for rosacea. Cynosure reports positive cosmetic consumer outlookRevance Data, AD Updates, FDA Actions
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-revance-data-ad-updates-fda-actions/18463/A US District Court judge blocks Stratus Pharmaceuticals of Miami and Sonar Products of Carlstadt, NJ from selling substandard dermatological products. Newly identified mutations in a gene called CARD11 may lead to atopic dermatitis. Surprising new evidence suggests atopic dermatitis is associated wHumphries to Valeant, Restylane Line Expands, 2016 Highlights
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-humphries-to-valeant-restylane-line-expands-2016-highlights/18709/The filler market in the US expands with FDA approval of Galderma's Restylane Refyne and Restalyne Define for the treatment of nasolabial folds in patients over the age of 21. The gels are manufactured with XpresHAn Technology, which allows a range of flexibility and support for varied patient needsTelemedicine and Access, Inappropriate Antibiotics, Industry Growth
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-telemedicine-and-access-inappropriate-antibiotics-industry-growth/18602/New research published online in JAMA Dermatology suggests that teledermatology improves access to care. Experts predict continued growth of telemedicine in dermatology. New estimates suggest that 30% of antibiotic prescriptions may be inappropriate. Dermatologists warn against antibiotic misuse andJoin Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciDerms Fight MOC; Cipher Buys Innocutis
https://practicaldermatology.com/topics/practice-management/dermwiretv-derms-fight-moc-cipher-buys-innocutis/18930/The AAD asks the American Board of Dermatology for changes to Maintenance of Certification (MOC) requirements; Jeanine Downie, MD and Heidi Waldorf, MD discuss problems with current and proposed requirements. Galderma presents data to support new investigational adapalene 0.3%/benzoyl peroxide 2.5%Multi-Use Devices: Recommendations for Assessment and Selection
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/multi-use-devices-recommendations-for-assessment-and-selection/19214/Jason Pozner, MD offers insights on the selection and use of multi-use devices in practice.